The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders

Osteoporosis International

Volumn 22, Issue 4, 2011, Pages 1133-1143

  Kelly, D L ^a   Myers, C S ^b   Abrams, M T ^c   Feldman, S ^a   Park, J ^c   McMahon, R P ^a   Shim, J C ^d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d Inje University College of Medicine   (South Korea)

Author keywords

Bone mineral density; Medicaid; Osteoporosis; Psychosis; Schizophrenia; Screening; Substance abuse

Indexed keywords

ADULT; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; HUMAN; MAJOR AFFECTIVE DISORDER; MEDICAID; OSTEOPOROSIS; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RISK; SCREENING; SUBSTANCE ABUSE;

AGE FACTORS; DIAGNOSIS, DUAL (PSYCHIATRY); EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MARYLAND; MASS SCREENING; MEDICAID; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PSYCHOTIC DISORDERS; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 79953304908     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1294-2     Document Type: Article

References (50)

1. CP Carney L Jones RF Woolson 2006 Medical comorbidity in women and men with schizophrenia: a population-based controlled study J Gen Intern Med 21 1133 1137 17026726 10.1111/j.1525-1497.2006.00563.x (Pubitemid 44506864)
2. L Dixon L Postrado J Delahanty PJ Fischer A Lehman 1999 The association of medical comorbidity in schizophrenia with poor physical and mental health J Nerv Ment Dis 187 496 502 10463067 10.1097/00005053-199908000-00006 1:STN:280:DyaK1Mzpt1elsQ%3D%3D (Pubitemid 29422604)
3. IM Salloum A Douaihy OK Ndimbie L Kirisci 2004 Concurrent alcohol and cocaine dependence impact on physical health among psychiatric patients J Addict Dis 23 71 81 15132343 10.1300/J069v23n02-05 (Pubitemid 38656242)
4. BE Havassy J Alvidrez KK Owen 2004 Comparisons of patients with comorbid psychiatric and substance use disorders: implications for treatment and service delivery Am J Psychiatry 161 139 145 14702262 10.1176/appi.ajp.161.1.139 (Pubitemid 38419319)
5. JA Mackell DJ Harrison DD McDonnell 2005 Relationship between preventative physical health care and mental health in individuals with schizophrenia: a survey of caregivers Ment Health Serv Res 7 225 228 16320105 10.1007/s11020-005-7454-x (Pubitemid 43013251)
6. DL Kelly 2006 Treatment considerations in women with schizophrenia J Womens Health (Larchmt) 15 1132 1140 10.1089/jwh.2006.15.1132 (Pubitemid 46157485)
7. DL Kelly RR Conley 2004 Sexuality and schizophrenia: a review Schizophr Bull 30 767 779 15954189 (Pubitemid 40469514)
8. D Bliuc ND Nguyen VE Milch TV Nguyen JA Eisman JR Center 2009 Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women JAMA 301 513 521 19190316 10.1001/jama.2009.50 1:CAS:528:DC%2BD1MXhtlyqs7Y%3D
9. NIH 2001 Consensus conference development panel on osteoporosis prevention, diagnosis, and therapy JAMA 285 785 795 10.1001/jama.285.6.785
10. PA Thomas 2007 Racial and ethnic differences in osteoporosis J Am Acad Orthop Surg 15 Suppl 1 S26 S30 17766786
11. National Osteoporosis Foundation. In. Washington, DC
12. V O'Keane 2008 Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia J Psychopharmacol 22 70 75 18477623 10.1177/0269881107088439
13. V O'Keane AM Meaney 2005 Antipsychotic drugs: a new risk factor for osteoporosis in young women with schizophrenia? J Clin Psychopharmacol 25 26 31 15643097 10.1097/01.jcp.0000150223.31007.e0 (Pubitemid 40129379)
14. DU Jung RR Conley DL Kelly DW Kim SH Yoon JH Jang JG Shin JC Shim 2006 Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study J Clin Psychiatry 67 1391 1396 17017825 10.4088/JCP.v67n0909 (Pubitemid 44583386)
15. JH Renn NP Yang CM Chueh CY Lin TH Lan P Chou 2009 Bone mass in schizophrenia and normal populations across different decades of life BMC Musculoskelet Disord 10 1 19118498 10.1186/1471-2474-10-1
16. AM Meaney V O'Keane 2007 Bone mineral density changes over a year in young females with schizophrenia: relationship to medication and endocrine variables Schizophr Res 93 136 143 17467954 10.1016/j.schres.2007.01.013 1:STN:280:DC%2BD2szjtVCnug%3D%3D (Pubitemid 46817924)
17. Shim J, Jung D-U, Oh M, Kong B, Kelly D (2009) Bone mineral density and osteoporosis risk in older patients with schizophrenia: a 3-4 year follow-up study. In International Congress on Schizophrenia Research. San Diego, CA
18. Frank RG, Glied S, Carter R (2006) Better but not well: mental health policy in the United States since 1950. Johns Hopkins Univ Pr
19. Pagano M, Gauvreau K (1993) Principles of biostatistics. Duxbury Press, Belmont
20. Studenmund AH (2006) Using econometrics: a practical guide. Addison-Wesley
21. SA Brown TA Guise 2009 Cancer treatment-related bone disease Crit Rev Eukaryot Gene Expr 19 47 60 19191756
22. Bromet EJ, Dew MA, Eaton WW (2002) Epidemiology of psychosis with special reference to schizophrenia. Wiley-Liss, Inc, New York
23. PK Adelmann 2003 Mental and substance use disorders among Medicaid recipients: prevalence estimates from two national surveys Adm Policy Ment Health 31 111 129 14756195 10.1023/B:APIH.0000003017.78877.56 (Pubitemid 37553467)
24. R Burge B Dawson-Hughes DH Solomon JB Wong A King A Tosteson 2007 Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025 J Bone Miner Res 22 465 475 17144789 10.1359/jbmr.061113 (Pubitemid 46797130)
25. HD Nelson M Helfand SH Woolf JD Allan 2002 Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 529 541 12230356 (Pubitemid 35024625)
26. AM McBean X Yu 2007 The underuse of screening services among elderly women with diabetes Diabetes Care 30 1466 1472 17351285 10.2337/dc06-2233 (Pubitemid 46871156)
27. JR Bishop B Alexander BC Lund TB Klepser 2004 Osteoporosis screening and treatment in women with schizophrenia: a controlled study Pharmacotherapy 24 515 521 15098807 10.1592/phco.24.5.515.33346 (Pubitemid 38420540)
28. HW Sampson 2002 Alcohol and other factors affecting osteoporosis risk in women Alcohol Res Health 26 292 298 12875040
29. TW Kim DP Alford A Malabanan MF Holick JH Samet 2006 Low bone density in patients receiving methadone maintenance treatment Drug Alcohol Depend 85 258 262 16860495 10.1016/j.drugalcdep.2006.05.027 1:CAS:528:DC%2BD28XhtFOjtb3N (Pubitemid 44666285)
30. EE Epstein K Fischer-Elber Z Al-Otaiba 2007 Women, aging, and alcohol use disorders J Women Aging 19 31 48 17588878 10.1300/J074v19n01-03
31. CM Lofthus EK Osnes HE Meyer IS Kristiansen L Nordsletten JA Falch 2006 Young patients with hip fracture: a population-based study of bone mass and risk factors for osteoporosis Osteoporos Int 17 1666 1672 16941194 10.1007/s00198-006-0176-0 1:STN:280:DC%2BD28rotlagtQ%3D%3D (Pubitemid 44477628)
32. EE Schoenbaum D Hartel Y Lo AA Howard M Floris-Moore JH Arnsten N Santoro 2005 HIV infection, drug use, and onset of natural menopause Clin Infect Dis 41 1517 1524 16231267 10.1086/497270 (Pubitemid 41579999)
33. D Becker O Liver R Mester M Rapoport A Weizman M Weiss 2003 Risperidone, but not olanzapine, decreases bone mineral density in female premenopausal schizophrenia patients J Clin Psychiatry 64 761 766 12934975 10.4088/JCP.v64n0704 1:CAS:528:DC%2BD3sXmsV2nu70%3D (Pubitemid 36897211)
34. JM Neuner X Zhang R Sparapani PW Laud AB Nattinger 2007 Racial and socioeconomic disparities in bone density testing before and after hip fracture J Gen Intern Med 22 1239 1245 17594131 10.1007/s11606-007-0217-1 (Pubitemid 47247292)
35. ML Gourlay LF Callahan JS Preisser PD Sloane 2007 Osteoporosis preventive care in white and black women in community family medicine settings South Med J 100 677 682 17639746 (Pubitemid 47056516)
36. P Pothiwala EM Evans KM Chapman-Novakofski 2006 Ethnic variation in risk for osteoporosis among women: a review of biological and behavioral factors J Womens Health (Larchmt) 15 709 719 10.1089/jwh.2006.15.709 (Pubitemid 44349849)
37. MC Hochberg 2007 Racial differences in bone strength Trans Am Clin Climatol Assoc 118 305 315 18528512
38. M Alegria P Chatterji K Wells Z Cao CN Chen D Takeuchi J Jackson XL Meng 2008 Disparity in depression treatment among racial and ethnic minority populations in the United States Psychiatr Serv 59 1264 1272 18971402 10.1176/appi.ps.59.11.1264
39. F Eskandari PE Martinez S Torvik TM Phillips EM Sternberg S Mistry D Ronsaville R Wesley C Toomey NG Sebring JC Reynolds MR Blackman KA Calis PW Gold G Cizza 2007 Low bone mass in premenopausal women with depression Arch Intern Med 167 2329 2336 18039992 10.1001/archinte.167.21.2329 (Pubitemid 350179528)
40. PW Gold ML Wong DS Goldstein HK Gold DS Ronsaville M Esler S Alesci A Masood J Licinio TD Geracioti Jr G Perini MD DeBellis C Holmes AN Vgontzas DS Charney GP Chrousos SM McCann MA Kling 2005 Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels in melancholia Proc Natl Acad Sci USA 102 8303 8308 15919819 10.1073/pnas.0503069102 1:CAS:528:DC%2BD2MXlsV2mtLk%3D (Pubitemid 40800084)
41. S Alesci PE Martinez S Kelkar I Ilias DS Ronsaville SJ Listwak AR Ayala J Licinio HK Gold MA Kling GP Chrousos PW Gold 2005 Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: clinical implications J Clin Endocrinol Metab 90 2522 2530 15705924 10.1210/jc.2004-1667 1:CAS:528:DC%2BD2MXkt1Wgsrk%3D (Pubitemid 40686286)
42. B Mezuk WW Eaton SH Golden G Wand HB Lee 2008 Depression, antidepressants, and bone mineral density in a population-based cohort J Gerontol A Biol Sci Med Sci 63 1410 1415 19126857
43. J RachBeisel J Scott L Dixon 1999 Co-occurring severe mental illness and substance use disorders: a review of recent research Psychiatr Serv 50 1427 1434 10543851 1:STN:280:DC%2BD3c%2FhtFGktQ%3D%3D (Pubitemid 29510953)
44. L Dixon E Dibietz P Myers R Conley D Medoff AF Lehman 1993 Comparison of DSM-III-R diagnoses and a brief interview for substance use among state hospital patients Hosp Community Psychiatry 44 748 752 8375835 1:STN:280: DyaK3szosl2jtw%3D%3D (Pubitemid 23226581)
45. DA Regier ME Farmer DS Rae BZ Locke SJ Keith LL Judd FK Goodwin 1990 Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study JAMA 264 2511 2518 2232018 10.1001/jama.264.19.2511 1:STN:280:DyaK3M%2FjvFOiug%3D%3D
46. RC Kessler WT Chiu O Demler EE Walters 2005 Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication Arch Gen Psychiatry 62 617 627 15939839 10.1001/archpsyc.62.6.617 (Pubitemid 40973437)
47. RG McCreadie 2002 Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study Br J Psychiatry 181 321 325 12356659 10.1192/bjp.181.4.321 (Pubitemid 35178564)
48. M Soyka M Albus N Kathmann A Finelli S Hofstetter R Holzbach B Immler P Sand 1993 Prevalence of alcohol and drug abuse in schizophrenic inpatients Eur Arch Psychiatry Clin Neurosci 242 362 372 8323987 10.1007/BF02190250 1:STN:280:DyaK3szht1yruw%3D%3D (Pubitemid 23225617)
49. DM Ziedonis D Smelson RN Rosenthal SL Batki AI Green RJ Henry I Montoya J Parks RD Weiss 2005 Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations J Psychiatr Pract 11 315 339 16184072 10.1097/00131746-200509000-00005 (Pubitemid 41540226)
50. AI Green CM Canuso MJ Brenner JD Wojcik 2003 Detection and management of comorbidity in patients with schizophrenia Psychiatr Clin North Am 26 115 139 12683263 10.1016/S0193-953X(02)00014-X (Pubitemid 36384351)